BioScrip Q3 EPS $(0.07) Misses $(0.02) Estimate, Sales $615.88M Beat $517.55M Estimate

BioScrip (NASDAQ:BIOS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.02) by 250 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same

Benzinga · 11/06/2019 11:24

BioScrip (NASDAQ:BIOS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.02) by 250 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $615.88 million which beat the analyst consensus estimate of $517.55 million by 19.00 percent. This is a 240.34 percent increase over sales of $180.962 million the same period last year.